• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study.糖尿病患者的糖化血红蛋白、血压和血脂控制:日本职业健康研究流行病学合作项目
PLoS One. 2016 Jul 20;11(7):e0159071. doi: 10.1371/journal.pone.0159071. eCollection 2016.
2
Achievement of national clinical practice recommendations among those in the Puerto Rican population with diabetes mellitus.波多黎各糖尿病患者群体对国家临床实践建议的落实情况。
P R Health Sci J. 2014 Dec;33(4):157-62.
3
A retrospective, cross-sectional study of real-world values of cardiovascular risk factors using a healthcare database in Japan.一项利用日本医疗数据库对心血管危险因素实际值进行的回顾性横断面研究。
BMC Cardiovasc Disord. 2014 Sep 17;14:120. doi: 10.1186/1471-2261-14-120.
4
Simultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients.美国退伍军人事务部初级保健患者中间糖尿病结局的同步控制
J Gen Intern Med. 2006 Oct;21(10):1050-6. doi: 10.1111/j.1525-1497.2006.00519.x.
5
Prevalence of diabetes and pre-diabetes among workers: Japan Epidemiology Collaboration on Occupational Health Study.劳动者中糖尿病和糖尿病前期的患病率:日本职业健康研究流行病学协作组
Diabetes Res Clin Pract. 2014 Oct;106(1):118-27. doi: 10.1016/j.diabres.2014.07.013. Epub 2014 Jul 22.
6
Type 1 diabetes management: Room for improvement.1 型糖尿病管理:仍有改进空间。
J Diabetes. 2023 Mar;15(3):255-263. doi: 10.1111/1753-0407.13368. Epub 2023 Feb 17.
7
Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33).血糖、血压和血脂控制不佳的患者中糖尿病视网膜病变的患病率及危险因素。Sankara Nethralaya 糖尿病视网膜病变流行病学和分子遗传学研究(SN-DREAMS,报告 33)。
Curr Eye Res. 2012 Jun;37(6):513-23. doi: 10.3109/02713683.2012.669005.
8
HEMOGLOBIN A1C, BLOOD PRESSURE, AND LDL-CHOLESTEROL CONTROL AMONG HISPANIC/LATINO ADULTS WITH DIABETES: RESULTS FROM THE HISPANIC COMMUNITY HEALTH STUDY/STUDY OF LATINOS (HCHS/SOL).西班牙裔/拉丁裔糖尿病成年患者的糖化血红蛋白、血压及低密度脂蛋白胆固醇控制情况:来自西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)的结果
Endocr Pract. 2017 Oct;23(10):1232-1253. doi: 10.4158/EP171765.OR. Epub 2017 Aug 17.
9
Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study: A Nationwide Multicenter Study.中国2型糖尿病患者的管理现状及其预测因素:一项全国性多中心研究 :一项全国性多中心研究。
Diabetes Metab Res Rev. 2015 Nov;31(8):811-6. doi: 10.1002/dmrr.2757.
10
The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study.中国新诊断 2 型糖尿病患者血糖控制、血压控制、血脂控制的危险因素:一项全国性前瞻性队列研究。
Sci Rep. 2019 May 22;9(1):7709. doi: 10.1038/s41598-019-44169-4.

引用本文的文献

1
Construction of a risk prediction model for hypertension in type 2 diabetes: Independent risk factors and nomogram.2型糖尿病患者高血压风险预测模型的构建:独立危险因素与列线图
World J Diabetes. 2025 May 15;16(5):102141. doi: 10.4239/wjd.v16.i5.102141.
2
Exploring factors predicting the effectiveness of oral semaglutide in Japanese individuals with type 2 diabetes switching from dipeptidyl peptidase 4 inhibitors: a pilot study.探索预测口服司美格鲁肽对从二肽基肽酶4抑制剂转换过来的日本2型糖尿病患者有效性的因素:一项试点研究。
Front Clin Diabetes Healthc. 2025 Mar 24;6:1520389. doi: 10.3389/fcdhc.2025.1520389. eCollection 2025.
3
Combined symptoms of diabetes distress, depression, and anxiety and their association with glycemic control in primary care patients with type 2 diabetes in Egypt.埃及2型糖尿病初级护理患者中糖尿病困扰、抑郁和焦虑的综合症状及其与血糖控制的关联
Diabetol Int. 2025 Jan 27;16(2):326-338. doi: 10.1007/s13340-025-00793-2. eCollection 2025 Apr.
4
Preoperative contributing factors and the remission of diabetes after metabolic surgery: the mediating role of preoperative triglyceride.术前影响因素与代谢手术后糖尿病的缓解:术前甘油三酯的中介作用
Eat Weight Disord. 2024 Mar 4;29(1):18. doi: 10.1007/s40519-024-01647-7.
5
Baseline treatments and metabolic control of 288,913 type 2 diabetes patients in a 10-year retrospective cohort in Malaysia.马来西亚一项为期 10 年的回顾性队列研究中 288913 例 2 型糖尿病患者的基线治疗和代谢控制情况。
Sci Rep. 2023 Oct 13;13(1):17338. doi: 10.1038/s41598-023-44564-y.
6
Control of diabetes, hypertension, and dyslipidemia in Jordan: a cross-sectional study.约旦糖尿病、高血压和血脂异常的控制:一项横断面研究。
Ann Med Surg (Lond). 2023 Mar 24;85(3):439-445. doi: 10.1097/MS9.0000000000000272. eCollection 2023 Mar.
7
Indicators of optimal diabetes care and burden of diabetes complications in Africa: a systematic review and meta-analysis.非洲最佳糖尿病护理指标和糖尿病并发症负担:系统评价和荟萃分析。
BMJ Open. 2022 Nov 8;12(11):e060786. doi: 10.1136/bmjopen-2022-060786.
8
Evaluation of Impact of a Pharmacist-Led Educational Campaign on Disease Knowledge, Practices and Medication Adherence for Type-2 Diabetic Patients: A Prospective Pre- and Post-Analysis.评价药师主导的教育活动对 2 型糖尿病患者疾病知识、实践和用药依从性的影响:前瞻性预分析和后分析。
Int J Environ Res Public Health. 2022 Aug 15;19(16):10060. doi: 10.3390/ijerph191610060.
9
Two-year administration of sodium-glucose co-transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes.在日本2型糖尿病患者中,为期两年的钠-葡萄糖协同转运蛋白2抑制剂给药显著降低了体脂,且这一效果独立于骨骼肌量或血糖改善情况。
Diabetol Int. 2021 May 21;13(1):117-123. doi: 10.1007/s13340-021-00512-7. eCollection 2022 Jan.
10
Glucose Regulation Beyond HbA in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort.胰岛素治疗的2型糖尿病中糖化血红蛋白(HbA)以外的血糖调节:来自DIALECT-2队列的真实世界证据
Diabetes Care. 2021 Jul 22;44(10):2238-44. doi: 10.2337/dc20-2241.

本文引用的文献

1
Current status of glucose, blood pressure and lipid management in type 2 diabetes clinic attendees in Isfahan, Iran.伊朗伊斯法罕2型糖尿病门诊患者的血糖、血压和血脂管理现状
J Diabetes Investig. 2015 Nov;6(6):716-25. doi: 10.1111/jdi.12349. Epub 2015 Apr 17.
2
Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.他汀类药物治疗增加糖尿病风险与胰岛素敏感性和胰岛素分泌受损有关:METSIM 队列的 6 年随访研究。
Diabetologia. 2015 May;58(5):1109-17. doi: 10.1007/s00125-015-3528-5. Epub 2015 Mar 10.
3
A cascade of care for diabetes in the United States: visualizing the gaps.美国糖尿病的连续护理:可视化差距。
Ann Intern Med. 2014 Nov 18;161(10):681-9. doi: 10.7326/M14-0019.
4
Prevalence of diabetes and pre-diabetes among workers: Japan Epidemiology Collaboration on Occupational Health Study.劳动者中糖尿病和糖尿病前期的患病率:日本职业健康研究流行病学协作组
Diabetes Res Clin Pract. 2014 Oct;106(1):118-27. doi: 10.1016/j.diabres.2014.07.013. Epub 2014 Jul 22.
5
Antihypertensive drugs and glucose metabolism.抗高血压药物与葡萄糖代谢。
World J Cardiol. 2014 Jul 26;6(7):517-30. doi: 10.4330/wjc.v6.i7.517.
6
Status of diabetes treatment in Japanese adults: an analysis of the 2009 Japan Society of Ningen Dock database.日本成年人糖尿病治疗现状:对2009年日本国民健康保险体检协会数据库的分析
Intern Med. 2014;53(14):1491-6. doi: 10.2169/internalmedicine.53.1876. Epub 2014 Jul 15.
7
Increasing achievement of the target goals for glycemic, blood pressure and lipid control for adults with diagnosed diabetes in Korea.韩国提高确诊糖尿病患者的血糖、血压和血脂控制目标达标率。
J Diabetes Investig. 2013 Sep 13;4(5):460-5. doi: 10.1111/jdi.12077. Epub 2013 Apr 11.
8
Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes.他汀类药物的使用与糖尿病和非糖尿病高血压患者队列中血糖控制较差相关。
Diabetol Metab Syndr. 2014 Apr 23;6:53. doi: 10.1186/1758-5996-6-53. eCollection 2014.
9
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).日本高血压学会高血压管理指南(JSH 2014)
Hypertens Res. 2014 Apr;37(4):253-390. doi: 10.1038/hr.2014.20.
10
Comparison of body mass index, waist circumference, and waist-to-height ratio for predicting the clustering of cardiometabolic risk factors by age in Japanese workers--Japan Epidemiology Collaboration on Occupational Health study.日本工人中按年龄比较体重指数、腰围和腰高比以预测心血管代谢危险因素聚集情况——日本职业健康流行病学合作研究
Circ J. 2014;78(5):1160-8. doi: 10.1253/circj.cj-13-1067. Epub 2014 Mar 24.

糖尿病患者的糖化血红蛋白、血压和血脂控制:日本职业健康研究流行病学合作项目

Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study.

作者信息

Hu Huanhuan, Hori Ai, Nishiura Chihiro, Sasaki Naoko, Okazaki Hiroko, Nakagawa Tohru, Honda Toru, Yamamoto Shuichiro, Tomita Kentaro, Miyamoto Toshiaki, Nagahama Satsue, Uehara Akihiko, Yamamoto Makoto, Murakami Taizo, Shimizu Chii, Shimizu Makiko, Eguchi Masafumi, Kochi Takeshi, Imai Teppei, Okino Akiko, Kuwahara Keisuke, Kashino Ikuko, Akter Shamima, Kurotani Kayo, Nanri Akiko, Kabe Isamu, Mizoue Tetsuya, Kunugita Naoki, Dohi Seitaro

机构信息

Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.

Tokyo Gas Co., Ltd., Tokyo, Japan.

出版信息

PLoS One. 2016 Jul 20;11(7):e0159071. doi: 10.1371/journal.pone.0159071. eCollection 2016.

DOI:10.1371/journal.pone.0159071
PMID:27437997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4954688/
Abstract

AIMS

The control of blood glucose levels, blood pressure (BP), and low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of diabetes complications; however, data are scarce on control status of these factors among workers with diabetes. The present study aimed to estimate the prevalence of participants with diabetes who meet glycated hemoglobin (HbA1c), BP, and LDL-C recommendations, and to investigate correlates of poor glycemic control in a large working population in Japan.

METHODS

The Japan Epidemiology Collaboration on Occupational Health (J-ECOH) Study is an ongoing cohort investigation, consisting mainly of employees in large manufacturing companies. We conducted a cross-sectional analysis of 3,070 employees with diabetes (2,854 men and 216 women) aged 20-69 years who attended periodic health examinations. BP was measured and recorded using different company protocols. Risk factor targets were defined using both American Diabetes Association (ADA) guidelines (HbA1c < 7.0%, BP < 140/90 mmHg, and LDL-C < 100 mg/dL) and Japan Diabetes Society (JDS) guidelines (HbA1c < 7.0%, BP < 130/80 mmHg, and LDL-C < 120 mg/dL). Logistic regression models were used to explore correlates of poor glycemic control (defined as HbA1c ≥ 8.0%).

RESULTS

The percentages of participants who met ADA (and JDS) targets were 44.9% (44.9%) for HbA1c, 76.6% (36.3%) for BP, 27.1% (56.2%) for LDL-C, and 11.2% (10.8%) for simultaneous control of all three risk factors. Younger age, obesity, smoking, and uncontrolled dyslipidemia were associated with poor glycemic control. The adjusted odds ratio of poor glycemic control was 0.58 (95% confidence interval, 0.46-0.73) for participants with treated but uncontrolled hypertension, and 0.47 (0.33-0.66) for participants with treated and controlled hypertension, as compared with participants without hypertension. There was no significant difference in HbA1c levels between participants with treated but uncontrolled hypertension and those with treated and controlled hypertension.

CONCLUSION

Data from a large working population, predominantly composed of men, suggest that achievement of HbA1c, BP, and LDL-C targets was less than optimal, especially in younger participants. Uncontrolled dyslipidemia was associated with poor glycemic control. Participants not receiving antihypertensive treatment had higher HbA1c levels.

摘要

目的

控制血糖水平、血压(BP)和低密度脂蛋白胆固醇(LDL-C)水平可降低糖尿病并发症的风险;然而,关于糖尿病患者这些因素控制情况的数据却很稀少。本研究旨在估计符合糖化血红蛋白(HbA1c)、血压和LDL-C推荐标准的糖尿病参与者的比例,并调查日本一大规模工作人群中血糖控制不佳的相关因素。

方法

日本职业健康流行病学协作研究(J-ECOH研究)是一项正在进行的队列研究,主要由大型制造企业的员工组成。我们对3070名年龄在20 - 69岁、参加定期健康检查的糖尿病员工(2854名男性和216名女性)进行了横断面分析。血压按照不同公司的方案进行测量和记录。危险因素目标依据美国糖尿病协会(ADA)指南(HbA1c < 7.0%,BP < 140/90 mmHg,LDL-C < 100 mg/dL)和日本糖尿病学会(JDS)指南(HbA1c < 7.0%,BP < 130/80 mmHg,LDL-C < 120 mg/dL)来定义。采用逻辑回归模型探索血糖控制不佳(定义为HbA1c≥8.0%)的相关因素。

结果

符合ADA(及JDS)目标的参与者比例分别为:HbA1c为44.9%(44.9%),血压为76.6%(36.3%),LDL-C为27.1%(56.2%),同时控制所有三个危险因素的为11.2%(10.8%)。年龄较小、肥胖、吸烟和血脂异常未得到控制与血糖控制不佳相关。与无高血压的参与者相比,接受治疗但血压未得到控制的参与者血糖控制不佳的调整比值比为0.58(95%置信区间,0.46 - 0.73),接受治疗且血压得到控制的参与者为0.47(0.33 - 0.66)。接受治疗但血压未得到控制的参与者与接受治疗且血压得到控制的参与者之间HbA1c水平无显著差异。

结论

来自以男性为主的大规模工作人群的数据表明,HbA1c、血压和LDL-C目标的达成情况不尽人意,尤其是在年轻参与者中。血脂异常未得到控制与血糖控制不佳相关。未接受抗高血压治疗的参与者HbA1c水平较高。